Skip to main content
Clinical Trials/NCT02579070
NCT02579070CompletedNot Applicable

Efficacy and Safety of Diabetic Foot Ulcer Prevention System (DFUPS) - a Single Blind Randomised Clinical Trial in Diabetic Foot Patients at High Risk of Foot Ulceration

King's College Hospital NHS Trust6 sites in 1 country110 target enrollmentStarted: February 8, 2016Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
110
Locations
6
Primary Endpoint
Percentage of patients developing a foot ulcer

Study Overview

Brief Summary

The purpose of this study is to investigate whether regular measurement of skin foot temperature with a novel device (DFUPS) will prevent ulcer recurrence in diabetic patients at high risk of foot ulceration. It is planned to regularly measure the temperature of the feet of people with diabetes who have already had a foot ulcer which has subsequently healed. These measurements should allow the identification of hotspots on the foot and may be helpful when advising about ulcer risk and providing preventative treatment. It is hoped to find out whether the regular use of thermal images taken with the DFUPS device together with standard foot treatment may reduce the number of people with diabetes developing ulcers or even prevent foot ulcers.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Participant)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Aged 18 years or older
  • Has either type 1 or type 2 diabetes
  • Has intact feet as defined by the absence of a skin breakdown below the malleoli.
  • Has neuropathy confirmed by impaired sensation to neurothesiometer (vibration perception threshold > 25 volts on one OR both feet)
  • Has a past history of ≥1 foot ulceration (s) which has (have) resolved in the last 3 months
  • Has palpable foot pulses on both feet (palpable posterior tibial artery pulse OR dorsalis pedis artery pulse OR both)
  • Has no history of peripheral arterial disease
  • Has footwear which in the opinion of the investigator is not likely to cause pressure damage
  • Must be able to provide meaningful written informed consent for the study

Exclusion Criteria

  • Is aged <18
  • Has foot deformity that in the opinion of the investigator would interfere with the interpreting of the results of the study.
  • Has previous history of foot surgery which in the opinion of the study investigator could interfere with the interpreting the results of the study
  • Has active foot ulceration and infection
  • Has active Charcot osteoarthropathy
  • Has established Charcot foot deformity that in the opinion of the study investigator would interfere with the interpreting of the results of the study.
  • Has any uncontrolled illness that, in the opinion of the study investigator, would interfere with interpreting the results of the study
  • Has an implantable electronic device

Arms & Interventions

DFUPS (visual and thermal images)

Experimental

Visual and thermal imaging with DFUPS and standard foot care. The study investigator will have access to the thermal and visual images captured with DFUPS.

Intervention: DFUPS (Device)

DFUPS ( visual images)

Placebo Comparator

Visual and blinded thermal imaging with DFUPS and standard foot care. The study investigator will have access only to the visual images and will be blinded to the thermal images which will be captured at each visit but accessed only at the end of the study.

Intervention: DFUPS (Device)

Outcomes

Primary Outcomes

Percentage of patients developing a foot ulcer

Time Frame: 12 months

Secondary Outcomes

  • Rate of change of score in quality of life from baseline and up to the final visit using the EQ-5D-5L(12 months)
  • Time to ulceration(12 months)

Investigators

Sponsor
King's College Hospital NHS Trust
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (6)

Loading locations...

Similar Trials